Japan Tobacco Company Description
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally.
The company operates through three segments: Tobacco Business, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products.
The company also provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks.
In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system.
Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces.
It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Industry | Tobacco |
| Sector | Consumer Staples |
| Employees | 53,239 |
| CEO | Junichi Fukuchi |
Contact Details
Address: 1-1, Toranomon 4-chome Tokyo, 105-6927 Japan | |
| Phone | 81 3 6636 2914 |
| Website | jt.com |
Stock Details
| Ticker Symbol | JAPAY |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | US4711052054 |
Key Executives
| Name | Position |
|---|---|
| Junichi Fukuchi | SVice President, Chief Executive Officer of Japanese Tobacco Business - Tobacco Business Planning - Tobacco Business |
| Masamichi Terabatake | President, Chief Executive Officer, President of Tobacco Business and Representative Director |
| Hiromasa Furukawa | Senior Vice President, Chief Financial Officer and Corporate Communications |
| Dinesh Babu Thotakura | General Manager of Media and Investor Relations Division |
| Kenji Ogura | Senior Vice President of Corporate Governance and Compliance |
| Osamu Hirose | Senior Vice President and General Counsel |
| Kei Nakano | Executive Vice President of Finance, Corporate Communications, Business Development and D-LAB and Representative Director |
| Koji Shimayoshi | Executive Vice President of CS, Sustainability, People, Culture, IT, Legal, OR, BA, Pharma and Food Business and Rep. Director |
| Muneaki Fujimoto | Senior Vice President and President of Pharmaceutical Business |
| Hisashi Ishikawa | Vice President and Head of Tobacco Business Planning Division |